TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
595
|
2,000 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
-449
|
25
|
1,488 |
| EBITDA |
-466
|
127
|
1,497 |
| Total assets |
1,341
|
2,244
|
2,424 |
| Current assets |
1,341
|
1,844
|
1,877 |
| Current liabilities |
79
|
537
|
588 |
| Equity capital |
1,247
|
1,592
|
1,712 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
2
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
93.0%
|
70.9%
|
70.6% |
| Turnover per employee |
0
|
595
|
2,000 |
| Profit as a percentage of turnover |
4.2%
|
74.4% | |
| Return on assets (ROA) |
-33.4%
|
1.1%
|
61.4% |
| Current ratio |
1697.5%
|
343.4%
|
319.2% |
| Return on equity (ROE) |
-36.0%
|
1.6%
|
86.9% |
| Change turnover |
-598
|
-1,244
|
1,473 |
| Change turnover % |
-100%
|
-68%
|
279% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.